hiren379
★    

India,
2011-08-09 05:22
(5082 d 07:56 ago)

Posting: # 7277
Views: 4,902
 

 Aberrant observation in Reference (EU) for FDC [PK / PD]

Hello Friends,
What shall be done if T/R for single subject is around 1000 due to very low R value. No issues in clinical/bio analytical conduct.

As per EU we calculated whether its AUC is less than 5% of average GLSM for reference.

But the value comes to 5.80

Please guide. Will this work to exclude the subject. It was a FDC where in the concentration of second drug is 0 but may be our method for first drug was good enough :-( to measure these limited concentrations...


Edit: For beginners: FDC = Fixed Dose Combination (Product) [Helmut]
d_labes
★★★

Berlin, Germany,
2011-08-10 12:07
(5081 d 01:10 ago)

@ hiren379
Posting: # 7278
Views: 4,027
 

 Aberrant observation in Reference (EU) for FDC

Dear Hiren!

❝ What shall be done if T/R for single subject is around 1000 due to very low R value. No issues in clinical/bio analytical conduct.


❝ As per EU we calculated whether its AUC is less than 5% of average GLSM for reference.


❝ But the value comes to 5.80


:ponder: Did you calculate the geometric mean of the AUC of the Reference without the aberrant value?

EMA guidance page 14: "...A subject is considered to have very low plasma concentrations if its AUC is less than 5% of reference medicinal product geometric mean AUC (which should be calculated without inclusion of data from the outlying subject)..." Emphasis by me.

I would expect a ratio T/R around 20 if the aberrant value is 5% of the mean.

Regards,

Detlew
UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,697 registered users;
98 visitors (1 registered, 97 guests [including 26 identified bots]).
Forum time: 13:18 CEST (Europe/Vienna)

Anyone who conducts an argument by appealing to authority
is not using his intelligence;
he is just using his memory.    Leonardo da Vinci

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5